Skip to main content
. Author manuscript; available in PMC: 2020 Sep 15.
Published in final edited form as: Clin Cancer Res. 2019 Dec 12;26(6):1338–1348. doi: 10.1158/1078-0432.CCR-19-1728

Figure 3. Selinexor-GEM-nab-paclitaxel retains TSPs in the nuclei of PDAC cellular models.

Figure 3.

L3.6pl or MiaPaCa-2 cells grown on slides (3000 cells/well) and were exposed to vehicle or a combination of selinexor (300 nM), GEM (150 nM) and nab-paclitaxel (1.5 nM) for 24 hrs followed by IF analysis for nuclear TSPs (FOXO3a, Hsp90 and PAR-4).